使:A 6

Tetsuharu Kaneko1, Chihiro Kanno1, Morio Yamazaki1

  • 1Department of Dentistry and Oral Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.

概括

针对舌状细胞癌 (TSCC) 的新型动脉内化疗实现了100%的反应率,避免了广泛的手术. 这种治疗在T3 TSCC患者中显示出高的疗效和安全性.